Ledger.Open graph →
SEC Form D · filed February 15, 2023

FlightPath Biosciences, Inc

Offering
$8.0M
Sold
$1.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Birmingham, MI
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (4)

Matthew Tindall · Birmingham, MIExec · DirectorMark De Souza · Chestnut Hill, MADirectorMark De Souza · Chestnut Hill, MADirectorMatthew Tindall · Birmingham, MIExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗